ATM and pachyonychia congenita: Approximately 10% of patients with aggressive PC carry germline pathogenic variants in genes with established roles in cancer predisposition (BRCA2, ATM, CHEK2, NBN, BRCA1, PALB2, BRIP1, BARD1).